Summary
The product TESTOS 250 mg/ml, manufactured by Driada Medical, underwent comprehensive laboratory analysis to validate its potency and content accuracy. The sample, identified by batch number 407630, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis revealed a measured concentration of 237.86 mg/ml of testosterone enanthate, compared to the labeled specification of 250 mg/ml. This result represents a 4.86% variance, indicating the product is slightly underdosed but still within a reasonable range of accuracy.
The sample was retested twice to ensure consistency and reliability of the results. As the analysis was funded and submitted by the manufacturer, these findings should be considered critically. Nevertheless, the laboratory’s transparency and the consistency of the results provide valuable insights for harm reduction purposes.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: TESTOS 250 mg/ml
- Active Ingredient: Testosterone Enanthate
- Batch Number: 407630
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #18686
- Testing Ordered: 21 February 2022
- Sample Received: 22 February 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 237.86 mg/ml
- Accuracy: 95.14% (4.86% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/18686_EBRNXMQ912QN
- Originally Published: https://thinksteroids.com/community/posts/2920248/
Evaluation of Manufacturer-Funded Testing
The testing for TESTOS 250 mg/ml was funded and submitted by the manufacturer, Driada Medical. Manufacturer-funded testing often necessitates careful scrutiny to account for potential biases, such as selective sample submissions. Despite this, the results were consistent across retests, and Janoshik Analytical has a strong reputation for transparency and reliability. Independent third-party testing could further corroborate these findings.
Conclusion
The analysis of TESTOS 250 mg/ml confirms a testosterone enanthate concentration of 237.86 mg/ml, with a 4.86% variance below the labeled specification. While slightly underdosed, the product demonstrates reasonable accuracy and consistency. This report provides valuable information for harm reduction purposes and aids in informed decision-making.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
